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Summary 
Pattents wtth prtmary amylotdosts may develop peripheral neuropathy as an early feature Sural nerve biopsy is reported to be 
a sensittve method for dmgnosmg amyloidosis m such patients. We identified nine pattents, ulttmately diagnosed as having 
amylotdosts, who were referred for peripheral neuropathy of undetermmed ettology. In six, a sural nerve btopsy demonstrated no 
amyloid Subsequent examination of other tissue or of the contralateral sural nerve eventually resulted m the correct diagnosis. 
We conclude that sural nerve biopsy may be less sensittve than previously believed for the dmgnosls of amyloidosis in pattents 
with peripheral neuropathy secondary to amyloid. When the chnical suspicion of amyloidosls is high, a nondiagnosttc sural nerve 
biopsy should not dtscourage the performance of further lnvesttgatwe studies 
Introduction 
Primary amyloidosls is a dxsorder in which the fi- 
brous protein amyloid may be deposited m virtually 
any tissue (Kyle and Greipp 1983; Cohen 1991). Smce 
peripheral neuropathy is frequently an early or pre- 
senting feature of amyloidosis (Kyle and Bayrd 1975; 
Kyle and Greipp 1983; Duston et al. 1989), the neurol- 
ogist may be called upon to evaluate patients who are 
ultimately found to have amyloidosts, but m whom this 
diagnosis has not yet been established. Previous series 
(Kelly et al. 1979; Kyle and Greipp 1983; Janssen et al. 
1986) have indicated a high diagnostic yield from sural 
nerve biopsy in patients with primary amyloidosls and 
peripheral neuropathy. We have recently evaluated 9 
patients for peripheral neuropathy of unclear etiology 
who were eventually diagnosed as having amyloidosts. 
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In 6 of these patients, Congo red or crystal violet 
staining of sural nerve biopsy sections as well as elec- 
tron microscopy failed to show amyloid deposits. This 
raises questions regarding the sensittvity of routine 
sural nerve biopsy in the diagnosis of amyloidosis, and 
emphasizes the need for further diagnostic workup of 
patients with neuropathy whose clinical presentations 
and laboratory studies suggest amylotdosis, but in whom 
routine studies of sural nerve are nondiagnostxc. 
Materials and methods 
We reviewed records of the Unwersity of Michigan 
Neuromuscular Clinic and the Geismger Medical Cen- 
ter Depar tment  of Neurology for the past 6 years, and 
identified 9 patients referred for peripheral neuropa- 
thy of undetermined etiology who were eventually di- 
agnosed as having amyloldosls. Amyloid was demon- 
strated m the inittal rectal biopsy in 2 patients and the 
initial sural nerve biopsy in one. The remaining 6 
patients are the subjects of this report 
None of the patients had systemic cancer, a history 
of excessive alcohol use, or other dlsorders known to 
cause neuropathy except for one pattent (patient 3), 
who had mild diabetes melhtus which was controlled 
by diet alone. All had undergone comprehensive evalu- 
ations to rule out other causes of neuropathy, including 
physical examinatton, complete blood count, Wester- 
gren sedtmentatton rate, ANA, glucose, electrolytes, 
BUN, creatmine, hver function tests, T4, TSH, vitamin 
Bt2 level, VDRL or RPR, and chest X-ray. High 
resolutmn agarose gel serum electrophorests, im- 
munoglobulm quantification, determination of kappa: 
lambda hght chain ratio, and if necessary immunofixa- 
tion of serum (Keren et al. 1988) were performed in 5 
of the patients, while one underwent serum immuno- 
electrophorests. 
Sural nerve biopsies, taken at the level of the ankle, 
were divided mto 2 sections tmmediately after surgery 
The portion for light microscopy was fixed m 10% 
formalin. One longitudinal and 1-3 cross-sections were 
then obtained and embedded in paraffin. These blocks 
were then cut at 2 or more levels. All were stained with 
hematoxyhn-eosin and with a stain for amylold (crystal 
violet in patient 4, Congo red in the others). Trichrome 
staining was also employed in all except patient 6. For 
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all patients, another portion of nerve was fixed in 
glutaraldehyde and dwided into 2 sections. One section 
was minced and the pieces embedded in Epon, and the 
other was processed in glycerol for teasing. At least 10 
blocks of epon-embedded material were examined on 
multiple 1 micron thick tolutdme-stained sections, and 
one or two of them were selected for electron m~- 
croscopy All blopstes were reviewed by a neuropathol- 
ogist (M.B. or J.T.) 
Case reports 
Two illustrative cases are described. 
eattent 2 
An 83-year-old man was admitted with a 6-month history of 
bilateral hand pain and arm weakness He had surgical t reatment for 
bilateral carpal tunnel syndromes 3 years previously and a cholecys- 
tectomy for abdominal pare 2 years previously On examination, 
there was diffuse mdd upper  and lower extremity weakness Achilles 
reflexes were absent Pinprick and vibration were decreased distally 
Serum protein electrophoresls and lmmunoflxatlon revealed an lgM 
lambda monoclonal gammopathy Bone marrow biopsy was normal 
TABLE 1 
CLINICAL A N D  H I S T O L O G I C A L  FINDINGS IN PATIENTS WITH P O L Y N E U R O P A T H Y  AND AMYLOIDOSIS  
Patient No Age at Sural nerve biopsy Other  tissue studied 
onse t / s ex  Symptom Biopsy Amyloid Type of tissue 
duration at findings (Congo red 
biopsy and EM) 
Time after Amylold 
sural nerve (Congo 
biopsy red) 
1 6 2 / F  10 months  Severe loss of  Negative Rectal biopsy 
small > large 
myelinated 
axons 
2 8 2 / M  36 months  Moderate  loss Negative Transbronchlal  biopsy of 
of small > large lung mass 
myehnated 
axons 
3 6 4 / M  15 months  Severe loss of Negatwe Contralateral sural nerve 
all myelinated 
axons 
4 6 6 / M  16 months  Moderate  loss Negative * 
of all myehnated 
axons 
5 6 6 / M  6 months  Moderate  loss Negative 
of small > large 
myelinated axons 
6 6 8 / M  5 months  Marked loss of Negative 
small > large 
myehnated axons 
Ileum from Ileostomy 
First rectal biopsy 
Second rectal biopsy 
Autopsy brachlal plexus, 
femoral nerve, phrenlc 
nerve, dorsal root ganglion 
Autopsy brachlal plexus 
Autopsy obturator nerve, 
anterior and posterior 
roots, heart  
1 month  
5 months  
4 months  
See text 
13 months  
16 months  
21 months  
10 months  












EM = electron microscopy, 
* CrystM violet and electron microscopy 
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Two skeletal surveys showed no bone lesions Electrodmgnostlc 
studies revealed an axonal polyrad~culoneuropathy Sural nerve 
biopsy was negatwe for amylold by Congo red staining and by 
electron microscopy A lung mass was ~dentlfled, and he underwent  
transbronchial biopsy which demonstra ted amylold 
Pattent 6 
A 68-year-old man  presented with a 4-month history ot burning 
paresthesms of the distal lower extremiUes and fingertips, accompa- 
nied by mldllne abdominal  numbness .  Examination revealed todd 
weakness of  foot dorslflexors and toe extensors Patellar reflexes 
were depressed,  and Achilles reflexes were absent These  was de- 
creased sensaUon to pin, hght  touch, and vibration m the distal lower 
extremtt~es, and decreased pm and hght touch sensation in the 
m~dhne abdomen Serum and urine tmmunoelectrophoreses  were 
normal  Electrodmgnostlc studies revealed an axonal polyneuropa- 
thy Sural nerve biopsy was negatwe for amylo~d by Congo red 
staining and by electron microscopy Sensory and motor deficits 
progressed and he died suddenly At autopsy, amyloid deposition 
was demonst ra ted  m obturator  nerve, anterior and posterior nerve 
roots, and heart  
Results 
Data from the 6 patients stud~ed are presented in 
Table 1. The youngest was 62 years old and 5 were 
male. All presented with dysesthetic limb pain and 
numbness. Strength varied from normal to severely 
impaired, and sensory loss was present an all. Four had 
monoclonal heavy or light chains in serum or urine. 
None was known to have amyloidosas at the time of 
presentation, and none had features of other organ 
involvement at that time 
The presence of a painful sensorlmotor neuropathy, 
often with a monoclonal gammopathy, led to consader- 
ation of amyloid neuropathy in all patients. Sural nerve 
was the first ttssue evaluated for amyloid in all. The 
time from onset of symptoms to sural nerve biopsy 
varied from 5 to 36 months. All biopsies revealed an 
axonal neuropathy, and none demonstrated amyload. 
After the nondiagnostic sural nerve biopsy, amylold 
was eventually identified in all patients by biopsy of 
other tissue or at autopsy 1 to 21 months after the 
initial sural nerve biopsy. Patient 3 was the only one to 
undergo a second sural nerve baopsy. While the first 
one was negative for amyloid, the second one, obtained 
4 months later, contained very small amounts of amy- 
loid on electron microscopy Patient 3 also was unique 
m that one other tissue which eventually was found to 
stain positive for amyloid (ileum) was actually obtained 
at another institution 2 months prior to the first sural 
nerve biopsy (13 months after onset of symptoms), but 
was not stained for amylold at that time. Once we 
suspected amyloidosis but were unable to demonstrate 
it on sural nerve biopsy, the ileal tissue previously 
removed was obtained and stained with Congo red, 
resulting in a diagnosis of amyloidosis 
Discussion 
Peripheral neuropathy occurs tn 13-35% of patxents 
with pnmary amyloidosts, may be the presenting symp- 
tom of the disease, and may be present for months to 
years before the diagnosis of amyloldosis is estabhshed 
(Kyle and Bayrd 1975; Kyle and Greipp 1983; Duston 
et al. 1989). Our patients possessed clinical features 
consistent with amyloid polyneuropathy, and some had 
monoclonal gammopathles. In such patients, a sural 
nerve biopsy frequently is performed to look for amy- 
loid deposits 
The yield of sural nerve biopsy in patients wtth 
primary amyloxdosts and peripheral neuropathy ts said 
to be high. One small series (14 patients) cited a yield 
of 86% (Kyle and Dyck 1993). A figure of over 90% 
has also been cited (Kelly 1985). Review of other data 
suggests that the yield may even approach 100% (Kelly 
et al. 1979; Kyle and Gretpp t983, Janssen et al, 1986). 
However, such data are derived from small numbers of 
patients. 
Our yield, while also based on a small number ol 
patients, is strikingly lower. One factor which may 
account for this is the timmg of the biopsy relattve to 
the pattern of amylold deposition within the peripheral 
nervous system. Proximal portions of the pertpheral 
nervous system are thought to be involved first, fol- 
lowed by breakdown of the blood-nerve barrier and 
distal amyloid deposition (De Navasquez and Treble 
1938; Verghese et al. 1983, Hanyu et al. 1989; Sobue et 
al. 1990; Antoine et al. 1991). Thus, a patient studied 
early in the course of amyloidosls may show amyloid 
deposition only in the proramal pertpheral nervous 
system. A study later tn the dlness may demonstrate 
amyloid more distally. Such a pattern of amyloid depo- 
sition would explain not only our initial nondmgnostic 
sural nerve biopsy results, but also the presence ot 
amyloid in the contralateral sural nerve ot patient 3 
several months later and the presence of amyloid in 
proximal nerve of two of our patients at autopsy. The 
high yield of sural nerve biopsies previously reported in 
amyloidosis (Kelly et al 1979; Kyle and Greipp 1983, 
Janssen et al. 1986; Kyle and Dyck 1993) may have 
resulted from a longer duration of peripheral nervous 
system involvement prior to the time of nerve btops~, 
although such data cannot be extracted from those 
reports. The durataon of symptoms in our patients at 
the time of sural nerve biopsy varied from 5 to 3t~ 
months, which we believe as representative of the tame 
a sural nerve biopsy usually would be obtained in such 
patients. 
Technical factors must be considered when compar- 
ing our low yield of sural nerve biopsy to the higher 
values prevaously published. Techniques for evaluating 
sural nerve btopsies vary from institution to mstttution. 
Because this was a retrospective study, control for 
biopsy technique and specimen handling was not possi- 
ble Arnyloid deposition within a nerve may be patchy, 
and possibly our yield could have been Increased by the 
use of very large numbers of  sections per nerve or 
staining for both Congo red and crystal violet. How- 
ever, this is often not practical in the usual clinical 
setting, and there is no data to indicate how helpful 
this might be We believe that our protocol for the 
processing and study of sural nerve biopsies, resulting 
m the review of cross and longitudinal Congo red or 
crystal wolet  sections as well as multiple sections for 
electron microscopy, reflects the type of  evaluation 
performed routinely in large institutions, so that our 
figures are of interest to clinicians and neuropatholo- 
g~sts revolved In the management  of  such patients A 
prospective study comparing techniques such as ours to 
other means of processing sural nerve biopsies would 
be helpful to address this issue. 
Although our series is small, these cases suggest the 
need for persistence in diagnostic workup if amyloldo- 
sis is strongly suspected as the cause of  peripheral 
neuropathy, since the yield of  routinely processed sural 
nerve biopsies in the diagnosis of  amyloidosis may be 
lower than previously believed When patients, particu- 
larly older males, present with a painful neuropathy 
and a monoclonal  protein in the serum or urine, the 
sural nerve biopsy may show only nerve fiber loss. In 
such cases, biopsy of additional tissue or eventually of 
the contralateral sural nerve may lead to an accurate 
diagnosis_ 
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